Mphatswe Wendy, Blanckenberg Natasha, Tudor-Williams Gareth, Prendergast Andrew, Thobakgale Christina, Mkhwanazi Nompumelelo, McCarthy Noel, Walker Bruce D, Kiepiela Photini, Goulder Philip
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
AIDS. 2007 Jun 19;21(10):1253-61. doi: 10.1097/QAD.0b013e3281a3bec2.
To determine the natural history of HIV infection following peripartum single-dose nevirapine (sd-NVP) prophylaxis in a resource-limited country, and to assess implications for antiretroviral therapy (ART) roll-out programmes.
Infants of HIV-infected mothers in KwaZulu-Natal, South Africa, were tested on days 1 and 28 to detect intrauterine (IU) and intrapartum (IP) infection. Infant follow-up included monthly viral load and CD4 cell measurement. ART was initiated at infant CD4 cell% < or = 20%.
In 740 infants born to 719 HIV-infected women, mother-to-child transmission (MTCT) was 10.3% (69% IU, 31% IP). Median viral load was higher in mothers of infants infected IP than IU (279 000 versus 86 600 copies/ml; P = 0.039) and lower in mothers of uninfected infants (median 26 750 copies/ml; P < 0.001). Peak viraemia was higher in infants infected IP than IU (5 160 000 versus 984 000 copies/ml; P < 0.001). Median viral load at birth in IU-infected infants (155 000 copies/ml) fell 1.4 log to 6510 copies/ml by day 5 and was beneath the detection limit using dried blood spot analysis in 38% of infants. CD4 cell% declined rapidly, to < or = 20% in 70% and < or = 25% in 85% [current World Health Organization (WHO) criteria for initiating ART] of infants by 6 months.
MTCT was reduced by sd-NVP through an effect on IP transmission. Where MTCT occurred despite NVP, two-thirds of transmissions arose IU; IP-infected babies were born to mothers with very high viral load. Disease progression was particularly rapid, 85% infants meeting WHO criteria for ART within 6 months. These findings argue for more effective MTCT-prevention programmes in resource-limited countries.
确定在资源有限的国家中,产后单剂量奈韦拉平(sd-NVP)预防后HIV感染的自然病程,并评估对抗逆转录病毒疗法(ART)推广计划的影响。
对南非夸祖鲁-纳塔尔省感染HIV的母亲所生婴儿在出生第1天和第28天进行检测,以检测宫内(IU)和产时(IP)感染情况。婴儿随访包括每月检测病毒载量和CD4细胞计数。当婴儿CD4细胞百分比≤20%时开始ART治疗。
在719名感染HIV的妇女所生的740名婴儿中,母婴传播(MTCT)率为10.3%(69%为宫内感染,31%为产时感染)。产时感染婴儿的母亲的病毒载量中位数高于宫内感染婴儿的母亲(分别为279 000拷贝/毫升和86 600拷贝/毫升;P = 0.039),未感染婴儿的母亲的病毒载量中位数更低(中位数为26 750拷贝/毫升;P < 0.001)。产时感染婴儿的病毒血症峰值高于宫内感染婴儿(分别为5 160 000拷贝/毫升和984 000拷贝/毫升;P < 0.001)。宫内感染婴儿出生时的病毒载量中位数(155 000拷贝/毫升)在第5天时下降了1.4个对数级至6510拷贝/毫升,并且在38%的婴儿中使用干血斑分析低于检测限。CD4细胞百分比迅速下降,到6个月时,70%的婴儿CD4细胞百分比≤20%,85%的婴儿CD4细胞百分比≤25%[符合世界卫生组织(WHO)目前启动ART治疗的标准]。
sd-NVP通过对产时传播的影响降低了MTCT。尽管使用了奈韦拉平仍发生MTCT的情况中,三分之二的传播发生在宫内;产时感染的婴儿出生于病毒载量非常高的母亲。疾病进展特别迅速,85%的婴儿在6个月内符合WHO的ART治疗标准。这些发现表明在资源有限的国家需要更有效的MTCT预防计划。